![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, August 20, 2013 8:39:56 AM
1) Friendly investor who appears to be committed to see Management execute to achieve future milestones = "Dominion"
and just may be the main Financing arm going forward = big capital raise looming here.
2) Multiple MANF Orphan IND's on the way = the technology platform is going to be HUGE (Parkinsons, Ischemic Heart disease, Opthamalogy, TBI, Diabetes....what next)?
3) Becton Dickinson alliance for LymPro (Alzheimers) - $500mm revenue potential = to be commercialized in 2014.
4) Nuropro Diagnostic blood test; can be used for the following future indications:
a)Parkinson’s disease
b)Alzheimer’s disease
c)Lou Gehrig’s disease (ALS)
d)Neuromuscular disease
e)Breast Cancer
f)Chonic Myelogenous Leukemia
5)Outstanding advisor team including people from Amgen, Novartis, Bayer, Bristol Myers Squibb.
I believe the worst is over for this company; as positive news continues to flow; the market cap. will adjust upward to reflect the progress and true underlying value of the asset base.
GLTA!!!
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM